2020
DOI: 10.1016/j.ejphar.2020.173452
|View full text |Cite
|
Sign up to set email alerts
|

In vivo efficacy studies of chromene-based compounds in triple-negative breast cancer – A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 34 publications
0
8
0
Order By: Relevance
“…1,2,3-TRIAZOLE-CONTAINING CHROMENE/COUMARIN DERIVATIVES Chromene (benzopyran) and coumarin (chromen-2-one) moieties are present in a large number of biologically active compounds, and their derivatives are potent inhibitors of a variety of proteins, such as EGFR, tyrosine kinase, ERK1/2, PI3K, HSP 90, Bax, STAT proteins, nuclear factor kappa-lightchain-enhancer of activated B cells (NF-κB), and telomerase associated with lung cancer (Manjinder et al, 2015;Manvendra et al, 2018;Al-Warhi et al, 2020;Oliveira-Pinto et al, 2020). Therefore, therapeutic drug candidates could be obtained by combination of 1,2,3-triazole and chromene/ coumarin for the treatment of lung cancer, even drug-resistant and multidrug-resistant (MDR) forms.…”
Section: Introductionmentioning
confidence: 99%
“…1,2,3-TRIAZOLE-CONTAINING CHROMENE/COUMARIN DERIVATIVES Chromene (benzopyran) and coumarin (chromen-2-one) moieties are present in a large number of biologically active compounds, and their derivatives are potent inhibitors of a variety of proteins, such as EGFR, tyrosine kinase, ERK1/2, PI3K, HSP 90, Bax, STAT proteins, nuclear factor kappa-lightchain-enhancer of activated B cells (NF-κB), and telomerase associated with lung cancer (Manjinder et al, 2015;Manvendra et al, 2018;Al-Warhi et al, 2020;Oliveira-Pinto et al, 2020). Therefore, therapeutic drug candidates could be obtained by combination of 1,2,3-triazole and chromene/ coumarin for the treatment of lung cancer, even drug-resistant and multidrug-resistant (MDR) forms.…”
Section: Introductionmentioning
confidence: 99%
“…Chromene and its derivatives are prominent scaffolds in medicinal chemistry, displaying significant bioactivities like anticancer, antifungal, antimicrobial, anti-inflammatory, antiproliferative and antiangiogenic activities. [49] Chromeno-[4,3b]pyridines have been reported as estrogen receptor βselective ligands, TNF-α inhibitors and as anti-inflammatory agents. [50] The structural motif of the chromeno-[4,3-b]pyridine provide ample scope for further molecular modifications and hence are sought after in medicinal chemistry.…”
Section: Chromeno-[34-c]-pyridinesmentioning
confidence: 99%
“…In particular, the possible anticancer activities have been the most investigated, but biological activities such as antimicrobial, antiviral, anti-inflammatory, antioxidant properties, treatment of skin disorders, and diabetes mellitus, among others, have also been reported. They are also increasingly used for the therapy of neurodegenerative diseases such as Down syndrome, Parkinson's disease, Alzheimer's disease, schizophrenia, and AIDS-related insanity [79][80][81][82][83][84].…”
Section: Chromenes and Xanthenesmentioning
confidence: 99%